Structural Basis of the Drug-binding Specificity of Human Serum Albumin

Hodgson, 2001, ADMET—turning chemicals into drugs, Nature Biotechnol., 19, 722, 10.1038/90761

Peters, 1995

Curry, 1998, Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites, Nature Struct. Biol., 5, 827, 10.1038/1869

Bhattacharya, 2000, Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin, J. Mol. Biol., 303, 721, 10.1006/jmbi.2000.4158

Petitpas, 2001, Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids, J. Mol. Biol., 314, 955, 10.1006/jmbi.2000.5208

Petitpas, 2003, Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia, Proc. Natl Acad. Sci. USA, 100, 6440, 10.1073/pnas.1137188100

Zunszain, 2003, Crystal structural analysis of human serum albumin complexed with hemin and fatty acid, BMC Struct. Biol., 3, 6, 10.1186/1472-6807-3-6

Wardell, 2002, The atomic structure of human methemalbumin at 1.9Å, Biochem. Biophys. Res. Commun., 291, 813, 10.1006/bbrc.2002.6540

Sudlow, 1975, The characterization of two specific drug binding sites on human serum albumin, Mol. Pharmacol., 11, 824

He, 1992, Atomic structure and chemistry of human serum albumin, Nature, 358, 209, 10.1038/358209a0

Herve, 1994, Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding, Clin. Pharmacokinet., 26, 44

Kratochwil, 2002, Predicting plasma protein binding of drugs: a new approach, Biochem. Pharmacol., 64, 1355, 10.1016/S0006-2952(02)01074-2

Valko, 2003, Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity, J. Pharm. Sci., 92, 2236, 10.1002/jps.10494

Colmenarejo, 2003, In silico prediction of drug-binding strengths to human serum albumin, Med. Res. Rev., 23, 275, 10.1002/med.10039

Petitpas, 2001, Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I, J. Biol. Chem., 276, 22804, 10.1074/jbc.M100575200

Bhattacharya, 2000, Binding of the general anesthetics propofol and halothane to human serum albumin: high-resolution crystal structures, J. Biol. Chem., 275, 38731, 10.1074/jbc.M005460200

Mao, 2001, Rational design of diflunisal analogues with reduced affinity for human serum albumin, J. Am. Chem. Soc., 123, 10429, 10.1021/ja015955b

Fehske, 1981, Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone, Mol. Pharmacol., 21, 387

Kragh-Hansen, 1988, Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin and other ligands, Mol. Pharmacol., 34, 160

Yamasaki, 1996, Characterization of site I on human serum albumin: concept about the structure of a drug binding site, Biochim. Biophys. Acta, 1295, 147, 10.1016/0167-4838(96)00013-1

Hajduk, 2003, Ligand binding to domain-3 of human serum albumin: a chemometric analysis, J. Comput. Aided Mol. Des., 17, 93, 10.1023/A:1025305520585

Bertucci, 1999, Site I on human albumin: differences in the binding of (R)- and (S)-warfarin, Chirality, 11, 675, 10.1002/(SICI)1520-636X(1999)11:9<675::AID-CHIR1>3.0.CO;2-C

Beaudry, 1999, Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model, Biomed. Chromatog., 13, 401, 10.1002/(SICI)1099-0801(199910)13:6<401::AID-BMC899>3.0.CO;2-C

Rich, 2001, High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE, Anal. Biochem., 296, 197, 10.1006/abio.2001.5314

Buchholz, 2002, Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding, Eur. J. Pharm. Sci., 15, 209, 10.1016/S0928-0987(01)00219-6

Colmenarejo, 2001, Cheminformatic models to predict binding affinities to human serum albumin, J. Med. Chem., 44, 4370, 10.1021/jm010960b

Saiakhov, 2000, Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs, Perspectives Drug Disc. Des., 19, 133, 10.1023/A:1008723723679

Sudlow, 1976, Further characterization of specific drug binding sites on human serum albumin, Mol. Pharmacol., 12, 1052

Fitos, 1999, Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate, Chirality, 11, 115, 10.1002/(SICI)1520-636X(1999)11:2<115::AID-CHIR6>3.0.CO;2-R

Chen, 2004, Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography, Nature Biotechnol., 22, 1445, 10.1038/nbt1022

Birkett, 1977, Effects of fatty acids on two specific drug binding sites on human serum albumin, Mol. Pharmacol., 13, 987

Vorum, 1996, Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy, J. Pharm. Pharmacol., 48, 870, 10.1111/j.2042-7158.1996.tb03990.x

Ivarsen, 1989, Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid, Dev. Pharmacol. Ther., 12, 19, 10.1159/000480978

Cistola, 1991, Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study, J. Clin. Invest., 87, 1431, 10.1172/JCI115149

Henderson, 1990, Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin, Biochem. Pharmacol., 40, 2543, 10.1016/0006-2952(90)90097-5

Tsutsumi, 1999, Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin, Pharm. Res., 16, 916, 10.1023/A:1018842506896

Sakai, 2001, Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin, Pharm. Res., 18, 520, 10.1023/A:1011014629551

Abraham, 2002, Application of hydrogen bonding calculations in property based drug design, Drug Discov. Today, 7, 1056, 10.1016/S1359-6446(02)02478-9

Sjoholm, 1979, Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles, Mol. Pharmacol., 16, 767

Kragh-Hansen, 1985, Relations between high-affinity binding sites of markers for binding regions on human serum albumin, Biochem. J., 225, 629, 10.1042/bj2250629

Sakai, 1995, Characterization of binding site of uremic toxins on human serum albumin, Biol. Pharm. Bull., 18, 1755, 10.1248/bpb.18.1755

Loun, 1994, Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin, Anal. Chem., 66, 3814, 10.1021/ac00093a043

Saifer, 1961, The free fatty acids bound to human serum albumin, J. Lipid Res., 2, 268, 10.1016/S0022-2275(20)39014-3

Curry, 1999, Fatty acid binding to human serum albumin: new insights from crystallographic studies, Biochim. Biophys. Acta, 1441, 131, 10.1016/S1388-1981(99)00148-1

Schumacher, 2003, Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR, Res. Microbiol., 154, 69, 10.1016/S0923-2508(02)00013-X

Sogami, 1968, Isomerization reactions of charcoal-defatted bovine plasma albumin. The N–F transition and acid expansion, Biochemistry, 7, 2172, 10.1021/bi00846a020

Carter, 1994, Preliminary crystallographic studies of four crystal forms of serum albumin, Eur. J. Biochem., 226, 1049, 10.1111/j.1432-1033.1994.01049.x

Stura, 1990, Analytical and production seeding techniques, Methods, 1, 38, 10.1016/S1046-2023(05)80145-8

1994, The CCP4 suite: programs for protein crystallography, Acta Crystallog. sect. D, 50, 760, 10.1107/S0907444994003112

Brünger, 1998, Crystallography & NMR system: a new software suite for macromolecular structure determination, Acta Crystallog. sect. D, 54, 905, 10.1107/S0907444998003254

Jones, 1991, Improved methods for building protein models in electron density maps and the location of errors in these maps, Acta Crystallog. sect. A, 47, 110, 10.1107/S0108767390010224

Fletcher, 1996, The United Kingdom Chemical Database Service, J. Chem. Inf. Comput. Sci., 36, 746, 10.1021/ci960015+

Kleywegt, 2003, Pound-wise but penny-foolish: how well do micromolecules fare in macromolecular refinement?, Structure (Camb), 11, 1051, 10.1016/S0969-2126(03)00186-2

van Aalten, 1996, PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules, J. Comput. Aided Mol. Des., 10, 255, 10.1007/BF00355047

Delano, 2002

Brady, 2000, Fast prediction and visualization of protein binding pockets with PASS, J. Comput. Aided Mol. Des., 14, 383, 10.1023/A:1008124202956